U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07470151) titled 'Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases' on March 10.
Brief Summary: A FIH, single arm, open-label, Investigator Initiated Trial (IIT) study to evaluate the safety and tolerability of EVM18001 in the treatment of active refractory autoimmune diseases (SLE, MG, and SSc), and determine the recommended dose for subsequent treatment. At the same time, the PK/PD characteristics of EVM18001 will be evaluated, preliminary efficacy will be observed, and related biomarkers and immunogenicity will be explored.
Study Start Date: March 12
Study Type: INTERVENTIONAL
Condition:
System Lupus Erythematosus...